Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians
- PMID: 22111602
- PMCID: PMC3292264
- DOI: 10.2217/pgs.11.132
Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians
Abstract
Aim: Genetic polymorphisms have the potential to influence drug metabolism and vary among ethnic groups. This study evaluated the correlation of genetic polymorphisms with nevirapine pharmacokinetics exposure in Malawians.
Materials & methods: CYP450 2B6, 2D6, 3A4 and 3A5, ABCB1 and constitutive androstane receptor and pregnane X receptor, were analyzed for polymorphisms in 26 subjects.
Results: Allele frequencies (variant) were: CYP2B6 514G>T (0.31) CYP2D6*4 (0.02); CYP2D6*17 (0.35); CYP3A4*1B (0.77); CYP3A5*3 (0.25); ABCB1 2677G>T (0.0), ABCB1 3435C>T (0.21), NR1I3 13711152T>C (0.02), NR1I2 44477T>C (0.10), NR1I2 63396C>T (0.33), NR1I2 6-bp indel (del: 0.17). CYP2B6 516G>T (non-wild-type/wild-type) correlated with nevirapine pharmacokinetic parameters; geometric mean ratios (95% CI): 1.75 (1.27-2.40) for area under the concentration time curve (AUC)(0-12 h), 1.58 (1.03-2.42) for C(0), and 0.53 (0.31-0.91) for clearance. In a multivariable model, nevirapine AUC increased by 1.5% per year of age (p < 0.0001), CYP2B6 516 T allele increased AUC by 92% (p < 0.0001), and CYP3A5*3 decreased AUC by 31% (p = 0.0027).
Conclusion: Allele frequencies were similar to other sub-Saharan African populations. The T allele for CYP2B6 516 was significantly associated with nevirapine exposure.
Figures
References
-
- Evans WE, McLeod HL. Pharmacogenomics – drug disposition, drug targets, and side effects. N Engl J Med. 2003;348(6):538–549. - PubMed
-
- Rotger M, Colombo S, Furrer H, et al. Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients. Pharmacogenet Genomics. 2005;15(1):1–5. First paper to describe CYP2B6 polymorphisms and effects on nevirapine therapy. - PubMed
-
- Bradford LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics. 2002;3(2):229–243. - PubMed
-
- Haas DW, Wu H, Li H, et al. MDR1 gene polymorphisms and phase 1 viral decay during HIV-1 infection: an adult aids clinical trials group study. J Acquir Immune Defic Syndr. 2003;34(3):295–298. - PubMed
-
- Haas DW, Ribaudo HJ, Kim RB, et al. Pharmacogenetics of efavirenz and central nervous system side effects: an adult aids clinical trials group study. AIDS. 2004;18(18):2391–2400. - PubMed
Websites
-
- Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of health and human services; Jan 10, 2011. [Accessed 15 May 2011]. pp. 1–166. www.Aidsinfo.Nih.Gov/contentfiles/adultandadolescentgl.Pdf.
-
- FAO Malawi nutrition profile. Nutrition and Consumer Protection Division. Food and Agriculture Organization of the United Nations; 2008. [Accessed 26 May 2010]. www.fao.org/ag/agn/nutrition/mwi_en.stm.
-
- NCBI dbSNP. www.ncbi.nlm.nih.gov/snp.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases